Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Belinda Welsh

Dr Belinda Welsh

Rosacea – Smarter Diagnosis and State of the Art Care

A/Prof Ralph Audehm & Prof Genie Pedagogos

A/Prof Ralph Audehm & Prof Genie Pedagogos

The Role of SGLT2 Inhibitors in Preventing Dialysis

Prof Jason Ong

Prof Jason Ong

Syphilis is on the Rise – What GPs Can do to Turn it Around

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

COPD Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025